Akari Therapeutics SG&A Expense (TTM) Insights

Akari Therapeutics Plc (AKTX)

0.2699 +0.02 (+10.03%) USD | NASDAQ | Dec 24, 12:59

0.2699 0.00 (0.00%) After-Hours: 13:59

View SG&A Expense (TTM) for AKTX.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View SG&A Expense (TTM) Chart

Start Trial

View Historical Data

Start Trial

View SG&A Expense (TTM) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View SG&A Expense (TTM) Benchmarks

Start Trial

DBV Technologies SA	28.71M
Cellectis SA	19.93M
Biodexa Pharmaceuticals Plc	5.354M
NuCana Plc	9.964M
Autolus Therapeutics Plc	129.58M